ESR1 and breast cancer: Mesenchymal stem cells (MSCs), a multipotent cell type that contributes to formation of bone, fat, and cartilage, are a major stromal cell type driving aggressive phenotypes of disseminated ER+ breast cancer cells in bone marrow.